Shogo Misumi
10PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.Belgin Sever, Cüneyt Türkeş, Yeliz Demir
|Dec 04, 2025
Targeting envelope lipids with 2,6‑di‑O‑methyl‑3‑acetyl‑β‑cyclodextrin impairs infectivity of SARS‑CoV‑2 and Japanese encephalitis virus.Daichi Kusakari, Naoki Kishimoto, Kazuyuki Oshiro
|Jun 13, 2025
Structural basis of the hepatitis B virus X protein in complex with DDB1.Hiroki Tanaka, Joao Diogo Dias, Basile Jay
|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi
|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut
|Feb 25, 2023
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi
Pageof 2
Frequent Collaborators
5 joint publications
Naoki Kishimoto
4 joint publications
Shin-Ichiro Hattori
4 joint publications
Nobuyo Higashi-Kuwata
4 joint publications
Haydar Bulut
4 joint publications
Debananda Das
4 joint publications
Hiroaki Mitsuya
3 joint publications
Hiromi Ogata-Aoki
3 joint publications
Yuki Takamatsu
3 joint publications
Nobutoki Takamune
3 joint publications
Hironori Hayashi
